Markets are expected to be active today as multiple companies draw attention with fresh business announcements, new deals, and important updates. From regulatory developments to stock-specific movements, here’s a snapshot of the top stocks to watch that may dominate headlines during today’s trading session.
On Wednesday, Indian benchmark indices snapped their three-day winning streak and closed lower. The Nifty 50 declined by 46.4 points (0.18%) to end at 25,476.10, while the Sensex dropped 176.43 points (0.21%) to close at 83,536.08.
India’s biggest IT firm, TCS, will report its Q1 earnings today.
Ambuja Cements announced that its subsidiary ACC Limited has started operations at its brownfield grinding unit in Sindri, Jharkhand. This new unit has a capacity of 1.5 million tonnes per annum.
The government-owned telecom company secured a ₹17.47 crore order from the Chhattisgarh government. This is RailTel’s third big project win this month.
The government has approved an Offer for Sale (OFS) in LIC to aid its disinvestment plans for FY26.
Enviro Infra, as the lead partner in a joint venture with AltoraPro Infrastructure, has bagged a ₹395 crore project from the Maharashtra Industrial Development Corporation.
The US FDA completed a pre-approval inspection of Emcure’s oncology facility in Sanand, Ahmedabad. The inspection ended with no Form 483 observations, showing compliance with all regulatory standards.
Airtel has set up a new fully-owned step-down subsidiary called Airtel Money Limited, which will focus on digital payment services.
Indosolar Limited, a Waaree Energies subsidiary, launched an Offer for Sale (OFS) of up to 10 lakh shares, representing 2.4% of its paid-up capital.
The Inter-Ministerial Group is set to review IDBI Bank’s share purchase agreement. After this, the proposal will go to higher government panels for final approval.
Also Read: Share Market Holiday List 2025!
Today’s session features several important updates across sectors—from TCS earnings and LIC’s disinvestment to RailTel’s new contract and Emcure Pharma’s regulatory progress. Investors should keep an eye on these stocks, especially as global market sentiment remains cautious amid tariff news.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jul 10, 2025, 8:54 AM IST
Kusum Kumari
Kusum Kumari is a Content Writer with 4 years of experience in simplifying financial market concepts. Currently crafting insightful content at Angel One, She specialise in breaking down complex topics into easy-to-understand pieces, blending expertise in market fundamentals and technical analysis.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
